In the most recent trading session, Synopsys (SNPS) closed at $601.55, indicating a -1.33% shift from the previous trading day.

Synopsys (SNPS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Goldman Sachs highlighted that a broadening customer base continues to drive outsized growth in Synopsys, Inc.

Bipolar disorder is a mental health condition characterized by extreme mood swings, with alternating periods of depression ...

Synopsys (SNPS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

The recently passed One Big Beautiful Bill Act (OBBBA) could have a disproportionate impact on nursing home residents ...

Buying $1000 In SNPS: If an investor had bought $1000 of SNPS stock 15 years ago, it would be worth $26,611.09 today based on a price of $587.59 for SNPS at the time of writing.

This study reveals how machine learning models uncover new genetic variants linked to Alzheimer’s, advancing predictive ...

Synopsys, in January 2024, agreed to buy Ansys for about $35B in cash and stock. Under the terms of the deal, Ansys ...

Shares of Synopsys Inc. SNPS slid 1.33% to $601.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.40% to 6,388.64 and ...

The cornerstone of OUD treatment remains medications for opioid use disorder (MOUD), including methadone, buprenorphine, and ...

China's market regulator has conditionally approved U.S. chip design software provider Synopsys' acquisition of engineering ...